Company research / NXL

Nexalin Technology, Inc. (NXL)

CIK 0001527352 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Nexalin Technology, Inc. reported revenue of $301.6K. Revenue grew 78.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

79.7%
Gross margin
-2781.7%
Operating margin
-2725.8%
Net margin
-219.4%
Return on year-end equity
78.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-02

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.